Logo image
Methylphenidate and the juvenile brain: enhancement of attention at the expense of cortical plasticity?
Journal article   Open access   Peer reviewed

Methylphenidate and the juvenile brain: enhancement of attention at the expense of cortical plasticity?

Kimberly R Urban and Wen-Jun Gao
Medical hypotheses, v 81(6), pp 988-994
Dec 2013
PMID: 24095262
url
https://doi.org/10.1016/j.mehy.2013.09.009View
Published, Version of Record (VoR) Open

Abstract

Age Factors Humans Neuronal Plasticity - drug effects Rats Methylphenidate - pharmacology Methylphenidate - adverse effects Attention Deficit Disorder with Hyperactivity - drug therapy Animals Prefrontal Cortex - drug effects Models, Biological Adolescent Attention Deficit Disorder with Hyperactivity - diagnosis Child
Methylphenidate (Ritalin) is the most commonly prescribed psychoactive drug for juveniles and adolescents. Used to treat attention-deficit/hyperactivity disorder (ADHD) and for cognitive enhancement in healthy individuals, it has been regarded as a relatively safe medication for the past several decades. However, a thorough review of the literature reveals that the age-dependent activities of the drug, as well as potential developmental effects, are largely ignored. In addition, the diagnosis of ADHD is subjective, leaving open the possibility of misdiagnosis and excessive prescription of the drug. Recent studies have suggested that early life exposure of healthy rodent models to methylphenidate resulted in altered sleep/wake cycle, heightened stress reactivity, and, in fact, a dosage previously thought of as therapeutic depressed neuronal function in juvenile rats. Furthermore, juvenile rats exposed to low-dose methylphenidate displayed alterations in neural markers of plasticity, indicating that the drug might alter the basic properties of prefrontal cortical circuits. In this review of the current literature, we propose that juvenile exposure to methylphenidate may cause abnormal prefrontal function and impaired plasticity in the healthy brain, strengthening the case for developing a more thorough understanding of methylphenidate's actions on the developing, juvenile brain, as well as better diagnostic measures for ADHD.

Metrics

10 Record Views
13 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Medicine, Research & Experimental
Logo image